Pascal Flüchter

Pascal Flüchter

Auto-generated profile, based on publicly available information

Pascal Flüchter

Institute of Physiology, University of Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2025 in Nature Immunology
Verified
Journal Article
Open access
PDF file
XFXiaogang Feng
Xiaogang Feng
TATilde Andersson
Tilde Andersson
PFPascal Flüchter
Pascal Flüchter
JGJulia Gschwend
Julia Gschwend
IBIvan Berest
Ivan Berest
CSChristoph Schneider
Christoph Schneider
The tuft cell–group 2 innate lymphoid cell (ILC2) circuit orchestrates rapid type 2 responses upon detecting microbially derived succinate and luminal helminths. Our findings delineate key mechanistic steps involving IP3R2 engagement and Ca2+ flux, governing interleukin-25 (IL-25) production by tuft cells triggered by succinate detection. While IL-17RB has a pivotal intrinsic role in ILC2 activation, it exerts a regulatory function in tuft cells. Tuft cells exhibit constitutive Il25 expression, placing them in an anticipatory state that facilitates rapid production of IL-25 protein for ILC2 activation. Tuft cell IL-17RB is crucial for restraining IL-25 bioavailability, preventing excessive tonic ILC2 stimulation due to basal Il25 expression. Supraoptimal ILC2 stimulation by IL-25 resulting from tuft cell Il17rb deficiency or prolonged succinate exposure induces a state of hypoproliferation in ILC2s, also observed in chronic helminth infection. Our study offers critical insights into the regulatory dynamics of IL-25 in this circuit, highlighting the delicate tuning required for responses to diverse luminal states.

26 September 2024 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PDF file
XFXiaogang Feng
Xiaogang Feng
PFPascal Flüchter
Pascal Flüchter
JTJeshua C. De Tenorio
Jeshua C. De Tenorio
CSChristoph Schneider
Christoph Schneider

4 August 2023 in Science Immunology
Verified
Journal Article
Closed access
PCPailin Chiaranunt
Pailin Chiaranunt
KBKyle Burrows
Kyle Burrows
LNLouis Ngai
Louis Ngai
STSiu Ling Tai
Siu Ling Tai
ECEric Y. Cao
Eric Y. Cao
AMArthur Mortha
Arthur Mortha
Maintaining macrophage (MΦ) heterogeneity is critical to ensure intestinal tissue homeostasis and host defense. The gut microbiota and host factors are thought to synergistically guide intestinal MΦ development, although the exact nature, regulation, and location of such collaboration remain unclear. Here, we report that microbial biochemical energy metabolism promotes colony-stimulating factor 2 (CSF2) production by group 3 innate lymphoid cells (ILC3s) within solitary isolated lymphoid tissues (SILTs) in a cell-extrinsic, NLRP3/P2X7R-dependent fashion in the steady state. Tissue-infiltrating monocytes accumulating around SILTs followed a spatially constrained, distinct developmental trajectory into SILT-associated MΦs (SAMs). CSF2 regulated the mitochondrial membrane potential and reactive oxygen species production of SAMs and contributed to the antimicrobial defense against enteric bacterial infections. Collectively, these findings identify SILTs and CSF2-producing ILC3s as a microanatomic niche for intestinal MΦ development and functional programming fueled by the integration of commensal microbial energy metabolism.

1 April 2021 in Clinical Nutrition
Verified
Journal Article
Open access
SMStefano Maric
Stefano Maric
PFPascal Flüchter
Pascal Flüchter
LGLaura Chiara Guglielmetti
Laura Chiara Guglielmetti
RSRalph Fabian Staerkle
Ralph Fabian Staerkle
TSTom Sasse
Tom Sasse
RVRaphael Vuille-dit-Bille
Raphael Vuille-dit-Bille
Plasma citrulline, a non-protein amino acid, is a biochemical marker of small intestine enterocyte mass in humans. Indeed, citrulline is highly correlated with residual bowel length in patients with short bowel syndrome. It is known to be synthesised in epithelial cells of the small intestine from other amino acids (precursors). Citrulline is then released into systemic circulation and interconverted into arginine in kidneys. If plasma citrulline concentration depends on abundance of intestinal amino acid transporters is not known. The aim of the present study was to explore whether plasma citrulline concentration correlates with the expression of intestinal amino acid transporters. Furthermore, we assessed if arginine in urine correlates with plasma citrulline. Duodenal samples, blood plasma and urine were collected from 43 subjects undergoing routine gastroduodenoscopy. mRNA expression of seven basolateral membrane amino acid transporters/transporter subunits were assessed by real-time PCR. Plasma and urine amino acid concentrations of citrulline, its precursors and other amino acids were analysed using High Performance Liquid Chromatography measurements. Amino acid transporter mRNA expression was correlated with blood plasma and urine levels of citrulline and its precursors using Spearman's rank correlation. Likewise, urine arginine was correlated with plasma citrulline. Plasma citrulline correlated with the mRNA expression of basolateral amino acid transporter LAT4 (Spearman's r = 0.467, p = 0.028) in small intestine. None of the other basolateral membrane transporters/transporter subunits assessed correlated with plasma citrulline. Plasma citrulline correlated with urinary arginine, (Spearman's r = 0.419, p = 0.017), but not with urinary citrulline or other proteinogenic amino acids in the urine. In this study, we showed for the first time that small intestinal basolateral LAT4 expression correlates with plasma citrulline concentration. This finding indicates that LAT4 has an important function in mediating citrulline efflux from enterocytes. Furthermore, urine arginine correlated with plasma citrulline, indicating arginine in the urine as possible additional marker for small intestine enterocyte mass. Finally, basolateral LAT4 expression along the human small intestine was shown for the first time.

9 September 2026 in Research Square
Verified
Preprint
Open access
PDF file
EVEduardo Villablanca
Eduardo Villablanca
XLXinxin Luo
Xinxin Luo
NHNing He
Ning He
QZQilin Zhu
Qilin Zhu
TATilde Andersson
Tilde Andersson
CSChristoph Schneider
Christoph Schneider
Protective type 2 immunity requires robust amplification during helminth infection, yet the epithelial mechanisms that restrain this feed-forward response remain poorly understood. Here, we identify the oxysterol-sensing nuclear receptor liver X receptor (LXR) as an epithelial transcriptional checkpoint that limits mucosal type 2 immunity. Pharmacological LXR activation reduced tuft cell and group 2 innate lymphoid cell (ILC2) expansion at steady state and following succinate stimulation. ILC2 responsiveness remained intact, as recombinant IL-25 fully restored tuft cell and ILC2 expansion, placing LXR upstream of IL-25-dependent circuit amplification. Consistently, epithelial-specific deletion of LXRα and LXRβ abolished the suppressive effects of LXR activation, demonstrating that epithelial LXR signaling is required to restrain the tuft cell-ILC2 circuit. Single-cell transcriptomic analysis further revealed that LXR preserves canonical tuft cell sensory programs while selectively limiting maturation toward the immune-associated tuft-2 state, thereby restricting inducible circuit amplification without disrupting epithelial chemosensing. Functionally, LXR activation impaired protective immunity against helminth infection, resulting in increased parasite burden. Together, these findings identify LXR as an epithelial transcriptional checkpoint that establishes the activation threshold of the tuft cell-ILC2 circuit, revealing a mechanism by which metabolic sensing controls mucosal type 2 immunity through regulation of epithelial cell states.